IN2014DN08610A - - Google Patents

Info

Publication number
IN2014DN08610A
IN2014DN08610A IN8610DEN2014A IN2014DN08610A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A IN 8610DEN2014 A IN8610DEN2014 A IN 8610DEN2014A IN 2014DN08610 A IN2014DN08610 A IN 2014DN08610A
Authority
IN
India
Prior art keywords
mammary gland
gland
peptides
cessation
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Jose Mario Iscovich
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of IN2014DN08610A publication Critical patent/IN2014DN08610A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN8610DEN2014 2012-03-19 2013-03-08 IN2014DN08610A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261612410P 2012-03-19 2012-03-19
PCT/IL2013/050214 WO2013140388A1 (en) 2012-03-19 2013-03-08 Peptides for management of lactation

Publications (1)

Publication Number Publication Date
IN2014DN08610A true IN2014DN08610A (ja) 2015-05-22

Family

ID=49221927

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8610DEN2014 IN2014DN08610A (ja) 2012-03-19 2013-03-08

Country Status (11)

Country Link
US (1) US9487557B2 (ja)
EP (1) EP2828281B1 (ja)
JP (1) JP6426599B2 (ja)
CN (1) CN104321336B (ja)
AU (1) AU2013236975B2 (ja)
BR (1) BR112014023087A8 (ja)
CA (1) CA2867557C (ja)
ES (1) ES2759980T3 (ja)
IL (1) IL234574B (ja)
IN (1) IN2014DN08610A (ja)
WO (1) WO2013140388A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
WO2021105152A1 (en) 2019-11-28 2021-06-03 Boehringer Ingelheim Vetmedica Gmbh Use of sglt-2 inhibitors in the drying-off of non-human mammals
BR112023022624A2 (pt) * 2021-04-28 2024-01-16 Mileutis Ltd Composições e métodos para modular distúrbios e condições mamárias

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391849B1 (en) 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
KR20040008130A (ko) * 2001-03-09 2004-01-28 메이지 세이카 가부시키가이샤 면역 증강제
ZA200710374B (en) * 2005-05-02 2009-06-24 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
EP1890720B1 (en) * 2005-05-02 2013-01-09 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
CA2695374A1 (en) * 2007-08-15 2009-02-19 Amunix, Inc. Compositions and methods for modifying properties of biologically active polypeptides

Also Published As

Publication number Publication date
BR112014023087A8 (pt) 2018-01-16
CA2867557A1 (en) 2013-09-26
JP6426599B2 (ja) 2018-11-21
EP2828281A4 (en) 2015-11-11
CN104321336B (zh) 2021-08-06
IL234574B (en) 2020-09-30
CA2867557C (en) 2020-03-10
EP2828281B1 (en) 2019-09-18
AU2013236975A1 (en) 2014-10-23
US9487557B2 (en) 2016-11-08
WO2013140388A1 (en) 2013-09-26
ES2759980T3 (es) 2020-05-12
EP2828281A1 (en) 2015-01-28
US20150093400A1 (en) 2015-04-02
AU2013236975B2 (en) 2017-10-19
CN104321336A (zh) 2015-01-28
JP2015516377A (ja) 2015-06-11
BR112014023087A2 (pt) 2017-06-20

Similar Documents

Publication Publication Date Title
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
PH12016501512B1 (en) Treatment for resistant acne
NI201500024A (es) Anticuerpos y vacunas para utilizarse en el tratamiento de cánceres por ror1 y para inhibir la metástasis.
GB2541571A (en) Pharmaceutical compositions
NZ730763A (en) Methods of treating a tauopathy
MX2015010312A (es) Metodos para tratamiento del melanoma.
MX2015006681A (es) Formulaciones de vancomicina estabilizadas.
SG10201903119QA (en) Polypeptide vaccine
PH12015501983B1 (en) Peptides and compositions for treatment of joint damage
MX2018007304A (es) Composiciones de interleucina-15 y sus usos.
MY168032A (en) Warm-Cool Beauty Treatment Device
IN2014DN10670A (ja)
MX364942B (es) Peptidos antimicrobianos.
EA201692554A1 (ru) Менингококковые вакцины
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
MY191539A (en) Streptococcal vaccine
MX2017001038A (es) Variantes de proteina de unión al factor h y metodos de uso de estas.
TN2014000518A1 (en) Reassortant btv and ahsv vaccines
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
IN2014DN08610A (ja)
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
MX2013010367A (es) Composiciones y metodos para la terapia y diagnostico de influenza.
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
MX2017005807A (es) Inmunoterapia especifica de multipeptidos t terapeuticos para el tratamiento de metastasis cerebrales.
GB201118201D0 (en) Novel peptides